What first started as a niche product that soon found its way onto grocery store shelves. CBD-infused foods, supplements, vitamins, drinks, and even skincare products are everywhere in 2020. CBD stands for cannabidiol, which is an ingredient found in cannabis and hemp. But because CBD contains less than 0.3% THC, which is the psychoactive compound found in marijuana, it’s legal to own and sell.

As of today, only one CBD-related product is approved by the U.S. Food and Drug Administration (FDA): a drug called Epidiolex that’s used to treat the symptoms of epilepsy. In addition, some studies suggest that CBD may help patients manage pain as well as psychological conditions such as schizophrenia, PTSD, anxiety, phobias, and more. However, the FDA hasn’t approved any CBD-containing products for treating those conditions.

CBD’s safety is also in question, as there hasn’t been much research on its effects on the human body, including its potential for interacting with other medications. In addition, because many products containing CBD are sold as supplements, they aren’t strictly regulated by the FDA. That means many of those products may be mislabeled and contain far less or far more CBD and even THC than indicated.

Because of that inconsistency and inaccurate labeling, the FDA sent waning letters to CBD product manufacturers in 2019 warning them of these errors. In addition, the FDA also warned manufacturers who falsely claimed that their CBD-containing products had unproven health benefits, such as being effective treatments for cancer and Alzheimer’s disease.

At Ferrer Poirot Feller Daniel, we believe the jury is still out on CBD and its effectiveness and safety. In the meantime, we will continue fighting for the rights of people injured by harmful drugs, supplements, and medical devices. Contact our drug injury lawyers today for a free consultation to find out how we can assist you.